End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
100 EGP | -.--% | -.--% | -.--% |
03-10 | October Pharma S.A.E Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | October Pharma S.A.E Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
Sales 2022 | 727M 15.19M 1.21B | Sales 2023 | 1.01B 21.12M 1.68B | Capitalization | 1.2B 25.05M 1.99B |
---|---|---|---|---|---|
Net income 2022 | 131M 2.73M 218M | Net income 2023 | 182M 3.8M 302M | EV / Sales 2022 | 2.08 x |
Net Debt 2022 | 316M 6.59M 525M | Net Debt 2023 | 279M 5.82M 463M | EV / Sales 2023 | 1.46 x |
P/E ratio 2022 |
10.6
x | P/E ratio 2023 |
7.98
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 11.51% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Tamer Ahmed
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 30/10/18 | |
Director/Board Member | - | - | |
Chief Executive Officer | - | - |
Date | Price | Change | Volume |
---|---|---|---|
02/05/24 | 100 | -.--% | 0 |
01/05/24 | 100 | -.--% | 0 |
30/04/24 | 100 | -.--% | 100 |
29/04/24 | 100 | -.--% | 0 |
24/04/24 | 100 | -.--% | 0 |
End-of-day quote Egyptian Exchange, April 29, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-.--% | 25.03M | |
+29.68% | 681B | |
+25.07% | 556B | |
-4.35% | 361B | |
+17.65% | 325B | |
+3.77% | 285B | |
+14.68% | 235B | |
+4.71% | 199B | |
-12.43% | 189B | |
-3.79% | 157B |
- Stock Market
- Equities
- OCPH Stock